DHR closes its $9.9B Masimo acquisition, adding AI-enabled patient-monitoring and sensor technologies to expand diagnostics solutions.

Danaher (NYSE:DHR) announced today that it completed its previously announced acquisition of Masimo (Nasdaq:MASI).

Danaher Corporation (NYSE: DHR), a global science and technology innovator, announced today that it has completed the acquisition ...

Danaher Corporation (NYSE: DHR), a global science and technology innovator, announced today that it has completed the acquisition of Masimo Corporation, a leading specialty diagnostics provider of ...

Medtronic has received Food and Drug Administration clearance for an updated version of its Nellcor pulse oximetry system.

This regulatory milestone follows news from earlier this year, when the company announced positive verification study results ...

Medtronic (NYSE:MDT) has received FDA 510(k) clearance for its Nellcor pulse oximetry system with the Nell-EQ intelligent ...

NICU Study Adds to the Evidence Demonstrating SET®’s Accuracy in Challenging Real-World Settings, With No Clinically Significant Differences in Performance Across Skin Pigmentation Categories or Race ...

Masimo Corp. today reported study data showing that its pulse oximetry technology accurately monitored hospitalized newborns of all skin tones without dangerous drops in blood oxygen. The findings ...

Apple can keep selling Apple Watches with its redesigned blood oxygen feature in the US after the ITC declined to revive Masimo’s ban. Apple has secured a significant victory in its years-long dispute ...